Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Deep Learning–Based ASPECTS Algorithm Enhances Reader Performance and Reduces Interpretation Time
7
Zitationen
12
Autoren
2024
Jahr
Abstract
BACKGROUND AND PURPOSE: ASPECTS is a long-standing and well-documented selection criterion for acute ischemic stroke treatment; however, the interpretation of ASPECTS is a challenging and time-consuming task for physicians with notable interobserver variabilities. We conducted a multireader, multicase study in which readers assessed ASPECTS without and with the support of a deep learning (DL)-based algorithm to analyze the impact of the software on clinicians' performance and interpretation time. MATERIALS AND METHODS: A total of 200 NCCT scans from 5 clinical sites (27 scanner models, 4 different vendors) were retrospectively collected. The reference standard was established through the consensus of 3 expert neuroradiologists who had access to baseline CTA and CTP data. Subsequently, 8 additional clinicians (4 typical ASPECTS readers and 4 senior neuroradiologists) analyzed the NCCT scans without and with the assistance of CINA-ASPECTS (Avicenna.AI), a DL-based, FDA-cleared, and CE-marked algorithm designed to compute ASPECTS automatically. Differences were evaluated in both performance and interpretation time between the assisted and unassisted assessments. RESULTS: < .05) when aided by the algorithm. CONCLUSIONS: With the assistance of the algorithm, readers' analyses were not only more accurate but also faster. Additionally, the overall ASPECTS evaluation exhibited greater consistency, fewer variabilities, and higher precision compared with the reference standard. This novel tool has the potential to enhance patient selection for appropriate treatment by enabling physicians to deliver accurate and timely diagnoses of acute ischemic stroke.
Ähnliche Arbeiten
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.
1993 · 12.190 Zit.
Correspondence - Tranexamic acid for traumatic brain injury
2005 · 11.734 Zit.
Tissue Plasminogen Activator for Acute Ischemic Stroke
1995 · 11.646 Zit.
Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis
2014 · 11.554 Zit.
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies
2002 · 10.204 Zit.